Vystar Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Vystar's inventory turnover ratio, the ratio that measures Vystar's ability to manage its supply chain, sequentially decreased to 0.27 in the first quarter 2026, which does not come as a surprise, as the Vystar continue to experience headwinds, which also impact its supply chain. Vystar's average inventory processing period in the Mar 31 2026 quarter, has increased to 1352 days, from 1014 days, in the Dec 31 2025 quarter.

Within Healthcare sector 366 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the fourth quarter 2025, to 1309.

VYST Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Vystar Corporation Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VYST Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	-17.56 %	-18.37 %	-20.1 %	-21.1 %	-16.09 %
Y / Y Cost of Sales Growth	-77.54 %	-50.44 %	-70.63 %	-77.18 %	-52.07 %
Inventory Turnover Ratio (TTM)	0.27	0.36	0.4	0.55	0.75
VYST's Total Ranking	# 1309	# 0	# 1205	# 1124	# 1757
Average inventory processing period	1358	1025	902	663	486
Seq. Inventory Growth	-2.21 %	-5.85 %	-6.58 %	-4.15 %	-3.17 %
Seq. Cost of Sales Growth	-57.42 %	-12.29 %	-4.07 %	-37.33 %	-6.01 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 163
Healthcare Sector	# 367
Overall Market	# 1309

Inventory Turnover Ratio Statistics
High	Average	Low
94.97	7.6	0.27
(March 31, 2015)		(Mar 31 2026)

VYST Company Profile >> Back to VYST Efficiency Comparisons >> Compare VYST Inventory Turnover Ratio to its Competitors

Financial Statements
Vystar's Inventories	$ 0 Millions	Visit VYST's Balance sheet
Vystar's Cost of Revenues TTM	$ 0 Millions	Visit VYST's Income Statement
What are VYST's Sales?		Visit VYST's Sales by Segment

Other Inventory Turnover Ratios
Vystar's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
VYST's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for VYST's Competitors
Inventory Turnover Ratio for VYST's Suppliers
Inventory Turnover Ratio for VYST's Customers

You may also want to know
VYST's Sales Growth Rates	VYST's Pe Price to earnings ratio	VYST's Receivables Turnover Ratio	VYST's Stock Quote
VYST's Net Income Growth Rates	VYST's Ps Price to Sales ratio	VYST's Sales per Employee	VYST's Asset Turnover Ratio
VYST's Net Margin	VYST's Pb Price to Book ratio	VYST's Financial Strength Ratios	VYST's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Establishment Labs Holdings Inc	0.77	$ 68.000 Millions	$ 89 Millions
Sintx Technologies Inc	0.72	$ 0.547 Millions	$ 1 Millions
Rafael Holdings Inc	0.72	$ 0.201 Millions	$ 0 Millions
Immunocore Holdings Plc	0.72	$ 4.690 Millions	$ 7 Millions
Igc Pharma Inc	0.70	$ 0.704 Millions	$ 1 Millions
Siga Technologies Inc	0.69	$ 32.487 Millions	$ 47 Millions
Milestone Scientific Inc	0.67	$ 2.579 Millions	$ 4 Millions
Picard Medical Inc	0.67	$ 4.731 Millions	$ 7 Millions
Xeris Biopharma Holdings Inc	0.64	$ 44.415 Millions	$ 69 Millions
Orchestra Biomed Holdings Inc	0.63	$ 0.178 Millions	$ 0 Millions
Envoy Medical Inc	0.61	$ 0.961 Millions	$ 2 Millions
Organogenesis Holdings Inc	0.60	$ 19.764 Millions	$ 33 Millions
Cvrx inc	0.59	$ 7.000 Millions	$ 12 Millions
Gyre Therapeutics Inc	0.59	$ 5.749 Millions	$ 10 Millions
Biomarin Pharmaceutical Inc	0.57	$ 760.883 Millions	$ 1,324 Millions
Envue Medical Inc	0.57	$ 0.708 Millions	$ 1 Millions
Verastem Inc	0.55	$ 0.977 Millions	$ 2 Millions
Heron Therapeutics Inc	0.52	$ 43.000 Millions	$ 82 Millions
Orthopediatrics Corp	0.49	$ 64.000 Millions	$ 130 Millions
Jaguar Health Inc	0.47	$ 4.417 Millions	$ 9 Millions
X4 Pharmaceuticals Inc	0.40	$ 1.639 Millions	$ 4 Millions
Clene Inc	0.40	$ 0.023 Millions	$ 0 Millions
Outlook Therapeutics Inc	0.40	$ 1.408 Millions	$ 4 Millions
Co diagnostics Inc	0.40	$ 0.399 Millions	$ 1 Millions
Regeneron Pharmaceuticals Inc	0.39	$ 1,248.700 Millions	$ 3,191 Millions
Soleno Therapeutics Inc	0.38	$ 3.898 Millions	$ 10 Millions
Guided Therapeutics Inc	0.37	$ 0.196 Millions	$ 1 Millions
Alpha Cognition Inc.	0.31	$ 1.300 Millions	$ 4 Millions
Aditxt Inc	0.31	$ 0.012 Millions	$ 0 Millions
Nexalin Technology Inc	0.31	$ 0.050 Millions	$ 0 Millions

Date modified: 2026-05-13T21:39:20+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.